Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Steensberg

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Journal of Physiology|March 18, 2003
Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humansAdam Steensberg, Christian P Fischer, Massimo Sacchetti, et al.
The Journal of Physiology|April 19, 2003
Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humansMark A Febbraio, Adam Steensberg, Charlotte Keller, et al.
Hormone Research|November 29, 2008
European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimensMoshe Phillip, Yael Lebenthal, Jan Lebl, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Interleukin-6 stimulates lipolysis and fat oxidation in humansGerrit van Hall, Adam Steensberg, Massimo Sacchetti, et al.
Cell Stress & Chaperones|January 7, 2005
Glucose ingestion attenuates the exercise-induced increase in circulating heat shock protein 72 and heat shock protein 60 in humansMark A Febbraio, Jose L Mesa, Jason Chung, et al.
Ebiomedicine|July 22, 2019
Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trialRahim Mohammad Naimi, Mark Hvistendahl, Nikolaj Nerup, et al.
Heart (British Cardiac Society)|April 1, 2018
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trialThomas Engstrøm, Lars Nepper-Christensen, Steffen Helqvist, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2019
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trialRahim M Naimi, Mark Hvistendahl, Lotte H Enevoldsen, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Physiology|March 18, 2003
Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humansAdam Steensberg, Christian P Fischer, Massimo Sacchetti, et al.
The Journal of Physiology|April 19, 2003
Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humansMark A Febbraio, Adam Steensberg, Charlotte Keller, et al.
Hormone Research|November 29, 2008
European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimensMoshe Phillip, Yael Lebenthal, Jan Lebl, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
Interleukin-6 stimulates lipolysis and fat oxidation in humansGerrit van Hall, Adam Steensberg, Massimo Sacchetti, et al.
Cell Stress & Chaperones|January 7, 2005
Glucose ingestion attenuates the exercise-induced increase in circulating heat shock protein 72 and heat shock protein 60 in humansMark A Febbraio, Jose L Mesa, Jason Chung, et al.
Ebiomedicine|July 22, 2019
Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trialRahim Mohammad Naimi, Mark Hvistendahl, Nikolaj Nerup, et al.
Heart (British Cardiac Society)|April 1, 2018
Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trialThomas Engstrøm, Lars Nepper-Christensen, Steffen Helqvist, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2019
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trialRahim M Naimi, Mark Hvistendahl, Lotte H Enevoldsen, et al.
Pageof 4